Previous Close | 3.4900 |
Open | 3.4600 |
Bid | 3.5100 x 3200 |
Ask | 3.5200 x 800 |
Day's Range | 3.4350 - 3.6300 |
52 Week Range | 2.4500 - 8.6300 |
Volume | |
Avg. Volume | 2,701,306 |
Market Cap | 397.378M |
Beta (5Y Monthly) | -0.05 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
It's not possible to invest over long periods without making some bad investments. But really bad investments should be...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2022 Earnings Call Transcript February 15, 2023 Operator: Good day. My name is Andrea, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. . Please be advised that […]
At this time, I would like to welcome everyone to the Karyopharm Therapeutics, fourth-quarter and full-year 2022 financial results conference call. As you can see on Slide 5, Karyopharm was founded in 2008 as an innovation and patient-focused company, developing first-in-class, oral selective inhibitor of nuclear export, which target XPO1 to improve patient outcomes in cancer.